Clinical Trial Update: Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

View source ↗

Summary

A clinical trial update describing a study to identify risk factors for brain recurrence in patients with HER2-positive localized breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Center Eugene Marquis | Conditions: HER2-positive Breast Cancer | Status: RECRUITING